Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$6.89 - $16.56 $220,156 - $529,141
-31,953 Reduced 12.26%
228,624 $2.25 Million
Q4 2021

Feb 11, 2022

SELL
$12.18 - $17.0 $6.74 Million - $9.41 Million
-553,586 Reduced 67.99%
260,577 $3.98 Million
Q3 2021

Nov 15, 2021

BUY
$11.61 - $15.99 $1.2 Million - $1.65 Million
103,163 Added 14.51%
814,163 $11 Million
Q2 2021

Aug 16, 2021

BUY
$12.25 - $18.61 $8.71 Million - $13.2 Million
711,000 New
711,000 $10.4 Million

Others Institutions Holding TALS

About Talaris Therapeutics, Inc.


  • Ticker TALS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,995,900
  • Market Cap $109M
  • Description
  • Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...
More about TALS
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.